172 related articles for article (PubMed ID: 22122052)
1. Epigenetics in Waldenström's macroglobulinemia.
Sacco A; Ghobrial IM; Roccaro AM
Epigenomics; 2010 Oct; 2(5):691-6. PubMed ID: 22122052
[TBL] [Abstract][Full Text] [Related]
2. Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.
Sacco A; Maiso P; Azab A; Azab F; Zhang Y; Liu Y; Ngo HT; Morgan B; Quang P; Issa G; Ghobrial IM; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):109-11. PubMed ID: 21454206
[TBL] [Abstract][Full Text] [Related]
3. Epigenomics in Waldenstrom's macroglobulinaemia.
Sacco A; Fenotti A; Bazzana S; Imberti L; Rossi G; Patterson CJ; Treon SP; Ghobrial IM; Roccaro AM
Best Pract Res Clin Haematol; 2016 Jun; 29(2):156-160. PubMed ID: 27825461
[TBL] [Abstract][Full Text] [Related]
4. microRNA aberrations in Waldenström macroglobulinemia.
Sacco A; Zhang Y; Maiso P; Manier S; Rossi G; Treon SP; Ghobrial IM; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):205-7. PubMed ID: 23474146
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology.
Sacco A; Issa GC; Zhang Y; Liu Y; Maiso P; Ghobrial IM; Roccaro AM
J Hematol Oncol; 2010 Oct; 3():38. PubMed ID: 20929526
[TBL] [Abstract][Full Text] [Related]
6. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
7. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
8. [Molecular basis of Waldenström macroglobulinemia].
Sevčíková S; Novák L; Kubiczková L; Dementyeva E; Ríhová L; Hájek R
Klin Onkol; 2012; 25(6):413-20. PubMed ID: 23301642
[TBL] [Abstract][Full Text] [Related]
9. Genetic factors and pathogenesis of Waldenström's macroglobulinemia.
Monge J; Braggio E; Ansell SM
Curr Oncol Rep; 2013 Oct; 15(5):450-6. PubMed ID: 23901022
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
11. Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center.
Merchionne F; Procaccio P; Dammacco F
Crit Rev Oncol Hematol; 2011 Oct; 80(1):87-99. PubMed ID: 21036057
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
[TBL] [Abstract][Full Text] [Related]
13. microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.
Roccaro AM; Sacco A; Chen C; Runnels J; Leleu X; Azab F; Azab AK; Jia X; Ngo HT; Melhem MR; Burwick N; Varticovski L; Novina CD; Rollins BJ; Anderson KC; Ghobrial IM
Blood; 2009 Apr; 113(18):4391-402. PubMed ID: 19074725
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
[TBL] [Abstract][Full Text] [Related]
15. Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and Rituximab.
Rabascio C; Laszlo D; Andreola G; Saronni L; Radice D; Rigacci L; Fabbri A; Frigeri F; Calabrese L; Billio A; Bertolini F; Martinelli G
Leuk Res; 2010 Apr; 34(4):454-7. PubMed ID: 19647871
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and epigenetics.
Sato F; Tsuchiya S; Meltzer SJ; Shimizu K
FEBS J; 2011 May; 278(10):1598-609. PubMed ID: 21395977
[TBL] [Abstract][Full Text] [Related]
17. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an animal model for Waldenström's macroglobulinemia.
Tsingotjidou AS; Emmanouilides CE; Siotou E; Poutahidis T; Xagorari A; Loukopoulos P; Sotiropoulos D; Bekiari C; Doulberis M; Givissis P; Fassas A; Anagnostopoulos A
Exp Hematol; 2009 Apr; 37(4):469-76. PubMed ID: 19302921
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic Waldenstrom's macroglobulinemia.
Alexanian R; Weber D; Delasalle K; Cabanillas F; Dimopoulos M
Semin Oncol; 2003 Apr; 30(2):206-10. PubMed ID: 12720137
[TBL] [Abstract][Full Text] [Related]
20. Familial Waldenstrom's macroglobulinemia.
McMaster ML
Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
